News


Unlocking efficiency in drug discovery: GE Healthcare’s The Pulse visits Sygnature Discovery

15th June 2017 – The Pulse recently interviewed Dr Scott Pollack, Associate Director, Biophysics and Enzymology, and Dr Paul Clewlow, Senior VP, Business Development, about how Sygnature Discovery is accelerating their ambitious clients’ drug discovery programs and helping them to increase their productivity through the application of cutting-edge technology, such as the Biacore 8K surface […]

Sygnature Discovery’s CEO Dr Simon Hirst talks to Chemistry World about growth

  14th June 2017 – What a difference a year makes!  Chemistry World caught up with Dr Simon Hirst, Sygnature Discovery’s Founder and CEO, one year after he was named as the Royal Society of Chemistry’s ‘Chemistry World Entrepreneur of the Year’ 2016. Since then the company has risen to even great heights and now […]

SelectScience Editorial Article: Insights into the UK’s Largest Independent Integrated Drug Discovery CRO

1st June 2017 – SelectScience recently interviewed Denise Swift, a Senior Bioscientist, Project and Team Leader at Sygnature Discovery.  Denise is responsible for evaluating new technologies to enhance Sygnature’s Bioscience capabilities – in particular, screening technologies, instrumentation and automation. The interview highlighted Sygnature Discovery’s novel approach to custom assay development and revealed some of the […]


View All News
Conferences

Meet Sygnature at the following Conferences throughout 2015:



Biotech Showcase/JP Morgan

9-11th January 2017
San Francisco USA


RSC OrgSyn 50

27-28 February 2017
Manchester UK


Proventa Medicinal Chemistry Strategy

14th March 2017
London



View All Conferences
Media

Sygnature Discovery



View All Media
Publications

KINASE INHIBITORS, FRICKEL, Fritz-Frieder

KINASE INHIBITORS, FRICKEL, Fritz-Frieder; FYFE, Matthew, Colin, Thor; MEGHANI, Premji; THOM, Stephen, Malcolm; (RespiVert Ltd. and TopiVert Ltd.), WO 2014076484 (2014).


PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne

PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne; KING-UNDERWOOD, John; LONGSHAW, Alistair Ian; MURRAY, Peter John; ONIONS, Stuart Thomas; TADDEI, David Michael Adrien; WILLIAMS, Jonathan Gareth; ITO, Kazuhiro; CHARRON, Catherine Elisabeth; (GB) (RespiVert Ltd. and TopiVert Ltd.), WO 2014033448 (2014).


KINASE INHIBITORS, FYFE, Matthew Colin Thor

KINASE INHIBITORS, FYFE, Matthew Colin Thor; MEGHANI, Premji; STENT, Matthew Alexander Henry; THOM, Stephen Malcolm; WALSHE, Claire Anne; (RespiVert Ltd. and TopiVert Ltd.), WO 2014033447 (2014).



View All Publications
Search


Get in Touch


Vacancies
  • Posted: May 3, 2017
    Senior Scientists in DMPK

  • Posted: March 16, 2017
    Commercial Contracts Manager


  • See more
    Latest news
  • Unlocking efficiency in drug discovery: GE Healthcare’s The Pulse visits Sygnature Discovery
  • Copyright © 2017 Sygnature Discovery

    Website built by AtomicMedia - Design by Freestyle.